InvestorsHub Logo
Followers 0
Posts 42
Boards Moderated 0
Alias Born 03/23/2017

Re: diarch post# 46108

Friday, 07/14/2017 12:46:20 PM

Friday, July 14, 2017 12:46:20 PM

Post# of 97079
If they assess the future value (potential) to include the J&J outcome, assuming a win, this company is worth about $4.41/share on just that number. (Assuming the lesser of the speculated settlements/awards of $400M. 1% of the worldwide diabetic supply market.) The current share count is 90.88M. What would that be after the conversion of the premium shares? Assuming a 14:1 ratio for conversion. Add in a reality factor of .50, and this company is still at about $2.20/share. Court costs are already covered by the previous award, and deposited with the legal firm. All of this is my speculation based on comments read previously from various posters. This is not meant to be a definitive calculation. Please do not go asking for links. This is just from general recall. $2.00/share seems to be a reasonable number as it doesn't even include future sales.